Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RMIX | CRH |
|---|---|---|
| Price | $11.51 | $80.91 |
| Change today | ▲ 2.95% | ▼ 0.68% |
| Market cap | $845.82M | $53.83B |
| Return, 3 months | -41.8% | -22.2% |
| Return, year to date | – | -34.4% |
| Return, 1 year | – | -30.3% |
| P/E (TTM) | -42.6 | 14.3 |
| P/B | 2.4 | 2.2 |
| P/E percentile vs own 5y | 33rd | 33rd |
| Dividend yield | – | 1.88% |
| Revenue growth (YoY, latest qtr) | +146.2% | +5.6% |
| Net profit growth (YoY) | -11,318.5% | +13.4% |
| Gross margin | 29.1% | 36.2% |
| Operating margin | 3.6% | 14.1% |
| Net margin | -38.2% | 9.9% |
| Return on equity | – | 16.4% |
| Analyst target vs. price | +88.3% | +66.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 25 | 33 |
| 30-day volatility | 48.5% | 26.0% |
| Max drawdown, 1 year | -55.0% | -37.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
